首页 >
法规速递
-
Document: Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion-2025/8/8
2025-08-10查看详情 > -
Document: Eltrombopag film-coated tablets 12.5 mg, 25 mg, 50 mg, 75 mg and powder for oral suspension 25 mg product-specific bioequivalence guidance-2025/9/25
2025-09-26查看详情 > -
关于公开征求《新生儿/低龄儿剂量推断技术指导原则（征求意见稿）》意见的通知-2025/11/4
2025-11-05查看详情 > -
Document: Keeping medicines safe: What actions can EMA take?-2025/12/3
2025-12-04查看详情 > -
Certification Process for Designated Medical Gases-2026/2/11
2026-02-12查看详情 > -
Document: Electronic product information (ePI) roadmap-2026/3/20
2026-03-23查看详情 > -
Page: Use of macrolides, lincosamides and streptogramins (MLS) in animals in the European Union - Scientific guideline-2026/4/24
2026-04-27查看详情 > -
Document: Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia-2026/6/5
2026-06-08查看详情 > -
Page: Horizon scanning: Identifying emerging trends-2026/7/17
2026-07-19查看详情 > -
国家药监局综合司关于国家药监局批准药品电子注册证统一使用“国家药品监督管理局 药品注册专用章”电子印章有关事宜的通知 药监综药注函〔2022〕609号-2022/10/31
2022-11-14查看详情 >
